Resultados de procura - Michael Daskalakis

  • Mostrando 1 - 12 Resultados de 12
Limitar resultados
  1. 1
    A Prospective Comparative Study of Moderate Versus High Protein Intake for Critically Ill Patients with Acute Renal Failure

    A Prospective Comparative Study of Moderate Versus High Protein Intake for Critically Ill Patients with Acute Renal Failure por Rinaldo Bellomo, John Seacombe Bapplsci, Michael Daskalakis, Michael Farmer, Christopher Wright, Geoffrey Parkin, Neil Boyce

    Publicado 1997
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome

    Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome por Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Ulrike Bacher, Thomas Pabst

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients

    Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients por Dilara Akhoundova, Katja Seipel, Ulrike Bacher, Marie-Noëlle Kronig, Naomi Porret, Gertrud Wiedemann, Michael Daskalakis, Thomas Pabst

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment

    Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment por Michael Daskalakis, TuDung T. Nguyen, Carvell T. Nguyen, Per Guldberg, Gabriele Köhler, Pierre W. Wijermans, Peter A. Jones, Michael Lübbert

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma

    CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma por Valerie Wittibschlager, Ulrike Bacher, Katja Seipel, Naomi Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle J. Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis

    Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis por Jochen Wilpert, K.-G. Fischer, P. Pisarski, Thorsten Wiech, Michael Daskalakis, Alan D. Ziegler, E. Neumann-Haefelin, Oliver Drognitz, Florian Emmerich, Gerd Walz, Marcel Geyer

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia

    Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia por Gabriela M. Baerlocher, Elisabeth Oppliger Leibundgut, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, Michael Daskalakis, Bart Burington, Monic J. Stuart, David S. Snyder

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors

    Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors por Michael Daskalakis, David Brocks, Yi-Hua Sheng, Md. Saiful Islam, Alzbeta Ressnerova, Yassen Assenov, Till Milde, Ina Oehme, Olaf Witt, Ashish Goyal, Alexander Kühn, Mark Hartmann, Dieter Weichenhan, Manfred Jung, Christoph Plass

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

    Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multic... por Philipp Berning, Evgenii Shumilov, Markus Maulhardt, Hristo Boyadzhiev, Andrea Kerkhoff, Simon Call, Christian Reicherts, Anna Ossami Saidy, Enver Aydilek, Michèle J. Hoffmann, Urban Novak, Michael Daskalakis, Norbert Schmitz, Matthias Stelljes, Gerald Wulf, Ulrike Bacher, Georg Lenz, Thomas Pabst

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts

    DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts por Ashish Goyal, Jens Bauer, Joschka Hey, Dimitris Papageorgiou, E. N. Stepanova, Michael Daskalakis, Jonas Scheid, Marissa L. Dubbelaar, Boris Klimovich, Dominic Schwarz, Melanie Märklin, Malte Roerden, Yu-Yu Lin, Tobias Ma, Oliver Mücke, Hans‐Georg Rammensee, Michael Lübbert, Fabricio Loayza‐Puch, Jeroen Krijgsveld, Juliane S. Walz, Christoph Plass

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

    Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party por Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Andrea Kühnl, Nathalie Fégueux, Michael Daskalakis, Nicolaus Kröger, Peter Dreger, Caroline Besley, Urs Schanz, Adrian Bloor, Arnold Ganser, Édouard Forcade, Lucía López‐Corral, Jakob Passweg, Urban Novak, Ivan Moiseev, Hélène Schoemans, Grzegorz Basak, Christian Chabannon, Anna Sureda, Diana Averbuch, Bertram Glaß, Rafael de la Cámara, Zinaida Perić

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats

    DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats por David Brocks, Christopher R. Schmidt, Michael Daskalakis, H. Josh Jang, Nakul M. Shah, Daofeng Li, Jing Li, Bo Zhang, Yiran Hou, Sara Laudato, Daniel B. Lipka, Johanna Schott, Holger Bierhoff, Yassen Assenov, Monika Helf, Alzbeta Ressnerova, Md. Saiful Islam, Anders M. Lindroth, Simon Haas, Marieke Essers, Charles D. Imbusch, Benedikt Brors, Ina Oehme, Olaf Witt, Michael Lübbert, Jan‐Philipp Mallm, Karsten Rippe, Rainer Will, Dieter Weichenhan, Georg Stoecklin, Clarissa Gerhäuser, Christopher C. Oakes, Ting Wang, Christoph Plass

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: